Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-08

Clinical Trial Update: A Study With Lu AG09222 in Adults With Migraine Who Have Not Been Helped by Prior Preventive Treatments [Phase 2]

View source ↗

Summary

Phase 2 trial update for Lu AG09222 in adults with migraine who did not respond to prior preventive treatments has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lu AG09222

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Migraine | Phase 2 | Status: COMPLETED | Results posted: 2024-02-08